SATELLITE SYMPOSIUM
(sponsored by INVATEC)

TREATMENT OF BELOW-THE-KNEE DISEASE : IS IT WORTHWHILE ?
Chairmen : A. STELLA - J-M. CARDON
Moderator : J. VAN DEN BERG

Topics :

. Clinical results and comparison with surgery - Future developments
P. PEETERS (Belgium)
. Economic impact of CLI-is endovascular treatment cost-effective
C. SETACCI (Italy)
. Pedal arch revascularization : technical virtuosity or real clinical improvement ?
M. MANZI (Italy)

Panel Discussion :

Faculty dinner

Welcome and opening ceremony
L.D. CASTELLANI (France)

Welcome on behalf of the University of Corsica
S.MAC GAW-PENITENTI (France)

Session I : CAROTID STENTING : THE EVIDENCE
Chairmen : E.B. DIETHRICH - C. SETACCI
Moderator : G.L. GILLING-SMITH

Introduction :
an outline of background and purpose of meeting

Part 1 : Safety (30 day stroke and death)
1. EVA 3S Trial summary - Critique
J.L. MAS (France)
2. SPACE Trial summary - Critique
H.H. ECKSTEIN (Germany) - P. RINGLEB (Germany)
3. ICSS Trial summary - Critique
J. BEARD (UK)
4. SAPPHIRE (Sx) Trial summary - Critique
M. MAKAROUN (USA) - G.L. GILLING-SMITH (UK)

Part 2 : Efficacy / Durability
1. EVA 3S (4 year data)
J.L. MAS (France)
2. SPACE (2 year data)
P. RINGLEB (Germany) - H.H. ECKSTEIN (Germany)
3 CAVATAS (8 year data)
J. BEARD (UK) - G.L. GILLING-SMITH (UK)

Coffee Break

Session II : CONSENSUS MEETING : DEFINING THE ROLE OF CAS
Chairmen : T.V. SCHROEDER - F. VEITH
Moderator : G. GILLING-SMITH

Interactive discussion with an international panel of experts

Panellists :

Neurology :
J.L. MAS - P. RINGLEB - G. FORD)
Surgery :
J. BEARD, R.NAYLOR, H.H. ECKSTEIN, G. BIASI, C. SETACCI, F.CRIADO, P.BERGERON, N. CHESHIRE, E.B. DIETHRICH, M. THOMPSON, J. WATELET
Radiology :
J. VAN DEN BERG, J.F. BONNEVILLE
Cardiology :
M. AMOR (France)

Session III : CAROTID STENTING IN ASYMPTOMATIC PATIENTS
Chairmen : N. CHESHIRE - G.L. GILLING-SMITH
Moderator : J. VAN DEN BERG

Topics :

The evidence for intervention
R. NAYLOR (UK)
Trial Update :
Space2
H.H. ECKSTEIN (Germany)
TACIT
J. BEARD (UK)
ACST2
A. HALLIDAY (UK)

Intervention before Cardiac Surgery - review of the evidence :
E.B. DIETHRICH (USA)

Lunch for all participants / Social activities.

Session IV : MEET THE EXPERTS / ROUND TABLE

_ Discussion 1
Carotid stenting/AAA

SESSION V : EVAR FOR RUPTURED ANEURYSM

Chairman : T. LARZON - F. NUMAN
Moderator : M. THOMPSON

Topics :

• Meta-analysis of literature
D. PALOMBO (Italy )
• Tips and tricks
M. LACHAT (CH)
• Do we need a randomized trial ?
- Yes : M. THOMPSON (UK) (IMPROVE trial)
- No : F. VEITH (USA) (World Registry)

SESSION VI : CASE REVIEW SESSION
Chairmen : M. LACHAT - J. BUSQUET
Moderator : J. VAN DEN BERG

Theme :

EVAR, disasters and cases I wish I had never started

Free Evening

Session VII : LOWER LIMB INTERVENTIONS
Chairmen : J. PALMAZ - F. VEITH
Moderator : J.M. CARDON

Topics :

  Critical appraisal of SFA stent trials
J. BLEYN (Belgium)
  State-of-the-art/current status absorbable stents
P. PEETERS (Belgium)
  Atherectomy devices : do they work ?
E.B. DIETHRICH (USA)

Panel Discussion

Coffee Break

Session VIII : (T) EVAR
Chairmen : P.BERGERON - J.P. VERHOYE
Moderator : M. MALINA

Topics :

TEVAR
o Should the left subclavian artery be preserved ?
J. BRUNKWALL (Germany)
o When should CSF drainage be employed ?
F. CRIADO (USA)
EVAR
o Is it safe to leave type I endoleaks until the first postoperative review
M. MALINA (Sweden)
o Is EVAR the treatment of choice for aorto-enteric fistula
L. LONN (Denmark)

Panel Discussion

Session IX : INNOVATION AND TECHNOLOGY
Chairmen : J. PALMAZ - F. CRIADO
Moderator : J. WATELET

Targeted molecular interaction : a new approach in vascular prosthetics
J. PALMAZ (USA)
Challenging anatomy in RAAA - EVAR is a good option
T. LARZON (Sweden)
Angioseal Evolution
M. AMOR (France)
Drug eluting balloons - concept and technology
M. NEWRLY (Switzerland)
Terumo :
J.M. CARDON (France)

Discussion

Lunch for all participants/ Social activities

MEET THE EXPERTS / ROUND TABLE

  Dicussion 2
  PAD/Endovenous therapy

Session XI : VARICOSE VEINS / ENDOVENOUS THERAPY
Chairman : M. PERRIN - F. VAN ELST
Moderator : J. BLEYN

Topics :

Varicose veins : endovenous RF Foam Therapy and laser ablation :
Debate J. BLEYN (Belgium) J.L. GERARD (France)
Thrombolysis in acute deep venous thrombosis
N. BEAKGAARD (Denmark)
Midterm results of ilio-caval venous thrombectomy
Y. ALIMI (France)

Discussion
M. BOUAYED (Algeria- - C. HAMEL-DESNOS (France)

Session XII : EVAR - TYPE II ENDOLEAK
Chairman : F. CRIADO - A. STELLA
Moderator : G.BIASI

Topics :

Type II endoleak can be prevented by preoperative embolization
L. INGLESE (Italy)
Type II endoleaks are dangerous and should be treated (mini debate)
- For : F. Veith (USA)
- Against : G.L. Gilling-SMITH (UK)

Social dinner

Session XIII : VASCULAR MALFORMATIONS
Chairman : F. STILLO
Moderator : J.F. BONNEVILLE

Topics :

Review of treatment of venous and arterio-venous malformations
o Surgery G. CAMELOT (France)
o Endovascular F. NUMAN (Turkey)

Discussion

Session XIV : BRAIN ATTACK : THE NEWHEART ATTACK ?
Chairman : G. BIASI - P. GOUNY
Moderator : G.L. GILLING-SMITH

Topics :

Pharmacology for acute stroke-review of the evidence :
P. RINGLEB (Germany)
Systemic thrombolysis :
G. FORD (USA)
Endovascular treatment of acute stroke :
J.F. BONNEVILLE (France)

Discussion

Coffee Break

Session XV : RANDOMISED TRIALS
Chaimen : E.B. DIETHRICH - J.C. VAN DEN BERG
Moderator : L. CASTELLANI (France)

Inherent problems in randomised clinical trials with observational / no treatment arms.
C. BUCKLEY (USA)

Debate/Motion : You do not need level I evidence to practice good medicine

For the motion : F. VEITH (USA)
Against the motion : G. GILLING-SMITH (UK)

Dicussion

Against the motion : R. NAYLOR (UK)
For the motion : N. CHESHIRE (UK)

Vote

Session XVI : CLOSING REMARKS AND SUMMARY OF THE WORKSHOP
J.C. VAN DEN BERG (CH)

ADJOURNMENT

Lunch (optional)